Chemed director sells 190 shares of stock
Chemed Corp director Patrick P. Grace reported a sale of 190 shares of Capital Stock on 2026-07-31 at $532.00 per share in an open market or private transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chemed Corp director Patrick P. Grace reported a sale of 190 shares of Capital Stock on 2026-07-31 at $532.00 per share in an open market or private transaction. After this sale, he directly owns 3,533 shares of Chemed stock. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Capital Stock | 190 | $532.00 | $101K |
Key Figures
Key Terms
Capital Stock financial
Sale in open market or private transaction financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Chemed (CHE) director Patrick P. Grace report?
Was the Chemed (CHE) insider sale made under a Rule 10b5-1 trading plan?
What is the size of the Chemed (CHE) insider sale in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.